Huang; Hua-Pin
Patent Applications and Registrations
Patent applications and USPTO patent grants for Huang; Hua-Pin.The latest application filed is for "controlled release hydrocodone formulations".
Company Profile
2.55.57
- Huang; Hua-Pin - Englewood Cliffs NJ
- Huang; Hua-Pin - Engelwood Cliffs NJ
- HUANG, HUA-PIN - Englewoods Cliff NJ
- Huang; Hua-Pin - Succasunna NJ
Patent Activity
| Patent | Date |
|---|---|
| Controlled Release Hydrocodone Formulations App 20190022086 - Oshlack; Benjamin ; et al. | 2019-01-24 |
| Controlled release hydrocodone formulations Grant 10,179,130 - Oshlack , et al. Ja | 2019-01-15 |
| Controlled Release Hydrocodone Formulations App 20180353502 - Oshlack; Benjamin ; et al. | 2018-12-13 |
| Pharmaceutical products Grant 10,092,519 - Oshlack , et al. October 9, 2 | 2018-10-09 |
| Methods of manufacturing oral dosage forms Grant 10,076,516 - Oshlack , et al. September 18, 2 | 2018-09-18 |
| Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same Grant 10,039,720 - Oshlack , et al. August 7, 2 | 2018-08-07 |
| Methods of manufacturing oral formulations Grant 10,022,368 - Oshlack , et al. July 17, 2 | 2018-07-17 |
| Methods of providing analgesia Grant 9,682,077 - Oshlack , et al. June 20, 2 | 2017-06-20 |
| Methods of providing analgesia Grant 9,675,611 - Oshlack , et al. June 13, 2 | 2017-06-13 |
| Controlled release hydrocodone formulations Grant 9,669,023 - Oshlack , et al. June 6, 2 | 2017-06-06 |
| Controlled release hydrocodone formulations Grant 9,669,024 - Oshlack , et al. June 6, 2 | 2017-06-06 |
| Controlled release hydrocodone formulations Grant 9,669,022 - Oshlack , et al. June 6, 2 | 2017-06-06 |
| Methods Of Manufacturing Oral Formulations App 20170151229 - Oshlack; Benjamin ; et al. | 2017-06-01 |
| Methods Of Providing Analgesia App 20170143697 - Oshlack; Benjamin ; et al. | 2017-05-25 |
| Methods Of Manufacturing Oral Dosage Forms App 20170136006 - Oshlack; Benjamin ; et al. | 2017-05-18 |
| Tamper Resistant Dosage Form Comprising Co-extruded, Adverse Agent Particles And Process Of Making Same App 20170135959 - Oshlack; Benjamin ; et al. | 2017-05-18 |
| Naltrexone hydrochloride compositions App 20170100337 - Oshlack; Benjamin ; et al. | 2017-04-13 |
| Controlled Release Hydrocodone Formulations App 20170087151 - Oshlack; Benjamin ; et al. | 2017-03-30 |
| Methods Of Providing Analgesia App 20170087152 - Oshlack; Benjamin ; et al. | 2017-03-30 |
| Controlled Release Hydrocodone Formulations App 20170087153 - Oshlack; Benjamin ; et al. | 2017-03-30 |
| Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same Grant 9,579,286 - Oshlack , et al. February 28, 2 | 2017-02-28 |
| Controlled release hydrocodone formulations Grant 9,572,804 - Oshlack , et al. February 21, 2 | 2017-02-21 |
| Controlled release hydrocodone formulations Grant 9,572,805 - Oshlack , et al. February 21, 2 | 2017-02-21 |
| Controlled release hydrocodone formulations Grant 9,526,724 - Oshlack , et al. December 27, 2 | 2016-12-27 |
| Controlled release hydrocodone formulations Grant 9,517,236 - Oshlack , et al. December 13, 2 | 2016-12-13 |
| Controlled release hydrocodone formulations Grant 9,504,681 - Oshlack , et al. November 29, 2 | 2016-11-29 |
| Pharmaceutical Compositions App 20160317456 - Oshlack; Benjamin ; et al. | 2016-11-03 |
| Controlled Release Hydrocodone Formulations App 20160228429 - Oshlack; Benjamin ; et al. | 2016-08-11 |
| Controlled Release Hydrocodone Formulations App 20160158223 - Oshlack; Benjamin ; et al. | 2016-06-09 |
| Controlled Release Hydrocodone Formulations App 20160158224 - Oshlack; Benjamin ; et al. | 2016-06-09 |
| Controlled Release Hydrocodone Formulations App 20160151361 - Oshlack; Benjamin ; et al. | 2016-06-02 |
| Controlled Release Hydrocodone Formulations App 20160151292 - Oshlack; Benjamin ; et al. | 2016-06-02 |
| Controlled Release Hydrocodone Formulations App 20160151288 - Oshlack; Benjamin ; et al. | 2016-06-02 |
| Controlled release hydrocodone formulations Grant 9,320,717 - Oshlack , et al. April 26, 2 | 2016-04-26 |
| Controlled release hydrocodone formulations Grant 9,289,391 - Oshlack , et al. March 22, 2 | 2016-03-22 |
| Controlled release hydrocodone formulations Grant 9,278,074 - Oshlack , et al. March 8, 2 | 2016-03-08 |
| Pharmaceutical Products App 20150366811 - OSHLACK; Benjamin ; et al. | 2015-12-24 |
| Controlled release hydrocodone formulations Grant 9,205,055 - Oshlack , et al. December 8, 2 | 2015-12-08 |
| Controlled release hydrocodone formulations Grant 9,205,056 - Oshlack , et al. December 8, 2 | 2015-12-08 |
| Controlled release hydrocodone formulations Grant 9,198,863 - Oshlack , et al. December 1, 2 | 2015-12-01 |
| Pharmaceutical product comprising a sequestered agent Grant 9,149,436 - Oshlack , et al. October 6, 2 | 2015-10-06 |
| Controlled Release Hydrocodone Formulations App 20150265537 - Oshlack; Benjamin ; et al. | 2015-09-24 |
| Controlled Release Hydrocodone Formulations App 20150258090 - Oshlack; Benjamin ; et al. | 2015-09-17 |
| Controlled Release Hydrocodone Formulations App 20150258089 - Oshlack; Benjamin ; et al. | 2015-09-17 |
| Controlled Release Hydrocodone Formulations App 20150238418 - Oshlack; Benjamin ; et al. | 2015-08-27 |
| Controlled Release Hydrocodone Formulations App 20150216810 - Oshlack; Benjamin ; et al. | 2015-08-06 |
| Controlled Release Hydrocodone Formulations App 20150216809 - Oshlack; Benjamin ; et al. | 2015-08-06 |
| Controlled Release Hydrocodone Formulations App 20150174121 - Oshlack; Benjamin ; et al. | 2015-06-25 |
| Controlled release hydrocodone Grant 9,060,940 - Oshlack , et al. June 23, 2 | 2015-06-23 |
| Controlled release hydrocodone formulations Grant 9,056,107 - Oshlack , et al. June 16, 2 | 2015-06-16 |
| Controlled release hydrocodone formulations Grant 9,056,052 - Oshlack , et al. June 16, 2 | 2015-06-16 |
| Controlled Release Hydrocodone Formulations App 20150148367 - Oshlack; Benjamin ; et al. | 2015-05-28 |
| Controlled release hydrocodone formulations Grant 9,023,401 - Oshlack , et al. May 5, 2 | 2015-05-05 |
| Controlled Release Hydrocodone Formulations App 20150110870 - Oshlack; Benjamin ; et al. | 2015-04-23 |
| Controlled release hydrocodone formulations Grant 8,980,291 - Oshlack , et al. March 17, 2 | 2015-03-17 |
| Controlled release hydrocodone formulations Grant 8,975,273 - Oshlack , et al. March 10, 2 | 2015-03-10 |
| Controlled release hydrocodone formulations Grant 8,951,555 - Oshlack , et al. February 10, 2 | 2015-02-10 |
| Controlled Release Hydrocodone Formulations App 20150037409 - Oshlack; Benjamin ; et al. | 2015-02-05 |
| Controlled Release Hydrocodone Formulations App 20140377348 - Oshlack; Benjamin ; et al. | 2014-12-25 |
| Controlled Release Hydrocodone Formulations App 20140271840 - Oshlack; Benjamin ; et al. | 2014-09-18 |
| Controlled Release Hydrocodone App 20140199394 - Oshlack; Benjamin ; et al. | 2014-07-17 |
| Controlled release hydrocodone Grant 8,715,721 - Oshlack , et al. May 6, 2 | 2014-05-06 |
| Controlled Release Hydrocodone Formulations App 20140112981 - Oshlack; Benjamin ; et al. | 2014-04-24 |
| Controlled release hydrocodone formulations Grant 8,647,667 - Oshlack , et al. February 11, 2 | 2014-02-11 |
| Controlled Release Hydrocodone Formulations App 20130302418 - Oshlack; Benjamin ; et al. | 2013-11-14 |
| Controlled Release Hydrocodone App 20130295177 - Oshlack; Benjamin ; et al. | 2013-11-07 |
| Controlled release hydrocodone Grant 8,551,520 - Oshlack , et al. October 8, 2 | 2013-10-08 |
| Controlled Release Hydrocodone App 20130158061 - Oshlack; Benjamin ; et al. | 2013-06-20 |
| Controlled release hydrocodone formulations Grant 8,361,499 - Oshlack , et al. January 29, 2 | 2013-01-29 |
| Controlled Release Hydrocodone Formulations App 20120263788 - OSHLACK; Benjamin ; et al. | 2012-10-18 |
| Controlled release hydrocodone formulations Grant 8,231,898 - Oshlack , et al. July 31, 2 | 2012-07-31 |
| Controlled release hydrocodone formulations Grant 8,142,811 - Oshlack , et al. March 27, 2 | 2012-03-27 |
| Controlled Release Hydrocodone Formulations App 20110262532 - Oshlack; Benjamin ; et al. | 2011-10-27 |
| Controlled release hydrocodone formulations Grant 7,943,174 - Oshlack , et al. May 17, 2 | 2011-05-17 |
| Controlled Release Hydrocodone Formulations App 20110038927 - Oshlack; Benjamin ; et al. | 2011-02-17 |
| Melt-extruded Orally Administrable Opioid Formulations App 20100172974 - Oshlack; Benjamin ; et al. | 2010-07-08 |
| Controlled release hydrocodone formulations App 20090202629 - Oshlack; Benjamin ; et al. | 2009-08-13 |
| Controlled release hydrocodone formulations Grant 7,514,100 - Oshlack , et al. April 7, 2 | 2009-04-07 |
| Melt-extrusion multiparticulates Grant 7,510,727 - Oshlack , et al. March 31, 2 | 2009-03-31 |
| Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same App 20070065364 - Oshlack; Benjamin ; et al. | 2007-03-22 |
| Pharmaceutical compositions App 20050266072 - Oshlack, Benjamin ; et al. | 2005-12-01 |
| Melt-extruded orally administrable opioid formulations App 20050089568 - Oshlack, Benjamin ; et al. | 2005-04-28 |
| Controlled release hydrocodone formulations App 20040266807 - Oshlack, Benjamin ; et al. | 2004-12-30 |
| Pharmaceutical products App 20040228924 - Oshlack, Benjamin ; et al. | 2004-11-18 |
| Melt-extrusion multiparticulates App 20040185096 - Oshlack, Benjamin ; et al. | 2004-09-23 |
| Melt-extruded orally administrable opioid formulations Grant 6,743,442 - Oshlack , et al. June 1, 2 | 2004-06-01 |
| Controlled release hydrocodone formulations Grant 6,733,783 - Oshlack , et al. May 11, 2 | 2004-05-11 |
| Melt-extruded orally administrable opioid formulations App 20040081694 - Oshlack, Benjamin ; et al. | 2004-04-29 |
| Melt-extrusion multiparticulates Grant 6,706,281 - Oshlack , et al. March 16, 2 | 2004-03-16 |
| Controlled release hydrocodone formulations App 20040047907 - Oshlack, Benjamin ; et al. | 2004-03-11 |
| Naltrexone hydrochloride compositions App 20030229111 - Oshlack, Benjamin ; et al. | 2003-12-11 |
| Stabilized sustained release tramadol formulations Grant 6,645,527 - Oshlack , et al. November 11, 2 | 2003-11-11 |
| Sustained release hydromorphone formulations exhibiting bimodal characteristics App 20030190358 - Oshlack, Benjamin ; et al. | 2003-10-09 |
| Melt-extrusion multiparticulates App 20030026839 - Oshlack, Benjamin ; et al. | 2003-02-06 |
| Controlled release hydrocodone formulations App 20020192277 - Oshlack, Benjamin ; et al. | 2002-12-19 |
| Stabilized sustained release tramadol formulations App 20020102302 - Oshlack, Benjamin ; et al. | 2002-08-01 |
| Sustained Release Hydromorphone Formulations Exhibiting Bimodal Characteristics App 20020006438 - OSHLACK, BENJAMIN ; et al. | 2002-01-17 |
| Melt-extrusion multiparticulates Grant 6,335,033 - Oshlack , et al. January 1, 2 | 2002-01-01 |
| Melt-extruded orally administrable opioid formulations App 20010036476 - Oshlack, Benjamin ; et al. | 2001-11-01 |
| Melt-extrusion Multiparticulates App 20010033865 - OSHLACK, BENJAMIN ; et al. | 2001-10-25 |
| Stabilized sustained release tramadol formulations Grant 6,306,438 - Oshlack , et al. October 23, 2 | 2001-10-23 |
| Melt-extruded orally administrable opioid formulations Grant 6,261,599 - Oshlack , et al. July 17, 2 | 2001-07-17 |
| Extruded multi-particulates Grant 5,965,161 - Oshlack , et al. October 12, 1 | 1999-10-12 |
| Extruded orally administrable opioid formulations Grant 5,958,452 - Oshlack , et al. September 28, 1 | 1999-09-28 |
| Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents Grant 5,424,301 - Huang , et al. June 13, 1 | 1995-06-13 |
| Neutral stabilization complex for CI-979 HCl, a cognition activator Grant 5,362,860 - Huang , et al. November 8, 1 | 1994-11-08 |
| Oral pharmaceutical composition for acid sensitive proteinaceous agents Grant 5,032,405 - Huang , et al. July 16, 1 | 1991-07-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 